Bacil Pharma (524516)
FAST GROWERScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹17.54 |
| Market Cap | ₹10.54 Cr |
| P/E Ratio | 93.78 |
| ROCE | -0.97% |
| ROE | 43.68% |
| Dividend Yield | 0% |
| Profit Growth | 166.67% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹26.69 — ₹61.8 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹1.14 |
Bacil Pharma trades with a P/E ratio of 93.78, ROCE of -0.97%, ROE of 43.68%, profit growth of 166.67%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer